On Monday, Heron Therapeutics Inc (NASDAQ: HRTX) opened lower -4.60% from the last session, before settling in for the closing price of $1.74. Price fluctuations for HRTX have ranged from $1.04 to $3.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 0.21%. Company’s average yearly earnings per share was noted 83.89% at the time writing. With a float of $150.63 million, this company’s outstanding shares have now reached $151.70 million.
Let’s determine the extent of company efficiency that accounts for 126 employees. In terms of profitability, gross margin is 67.55%, operating margin of -17.61%, and the pretax margin is -19.0%.
Heron Therapeutics Inc (HRTX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Heron Therapeutics Inc is 0.96%, while institutional ownership is 80.05%.
Heron Therapeutics Inc (HRTX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 83.89% per share during the next fiscal year.
Heron Therapeutics Inc (NASDAQ: HRTX) Trading Performance Indicators
Check out the current performance indicators for Heron Therapeutics Inc (HRTX). In the past quarter, the stock posted a quick ratio of 1.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.18, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.06 in one year’s time.
Technical Analysis of Heron Therapeutics Inc (HRTX)
Looking closely at Heron Therapeutics Inc (NASDAQ: HRTX), its last 5-days average volume was 0.93 million, which is a drop from its year-to-date volume of 1.37 million. As of the previous 9 days, the stock’s Stochastic %D was 32.68%. Additionally, its Average True Range was 0.11.
During the past 100 days, Heron Therapeutics Inc’s (HRTX) raw stochastic average was set at 55.86%, which indicates a significant increase from 21.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.76% in the past 14 days, which was lower than the 97.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6066, while its 200-day Moving Average is $2.2355. However, in the short run, Heron Therapeutics Inc’s stock first resistance to watch stands at $1.7200. Second resistance stands at $1.7800. The third major resistance level sits at $1.8100. If the price goes on to break the first support level at $1.6300, it is likely to go to the next support level at $1.6000. Now, if the price goes above the second support level, the third support stands at $1.5400.
Heron Therapeutics Inc (NASDAQ: HRTX) Key Stats
There are currently 152,095K shares outstanding in the company with a market cap of 252.48 million. Presently, the company’s annual sales total 127,040 K according to its annual income of -110,560 K. Last quarter, the company’s sales amounted to 32,810 K and its income totaled -4,850 K.
